Literature DB >> 35821894

Access to 3D Alicyclic Amine-Containing Fragments through Transannular C-H Arylation.

Melissa Lee1, Ashley Adams2, Philip B Cox2, Melanie S Sanford1.   

Abstract

In this Letter, we adapt a recently reported Pd-catalyzed transannular C(sp3)-H arylation of alicyclic amines for applications in fragment-based drug discovery (FBDD). We apply this method to the synthesis of a series of 6-arylated 3-azabicyclo[3.1.0]hexanes that are rule-of-three compliant fragments. Several modifications were made to the Pd-catalyzed C-H arylation method to enhance its utility in fragment synthesis. These include the use of microwave heating to shorten reaction times to under 1 h and the development of new approaches for directing group cleavage. Finally, we demonstrate that this fragment library falls within desirable physicochemical space for FBDD applications.

Entities:  

Keywords:  amines; arylation; directed C–H functionalization; directing group; fragment based drug discovery; microwave; palladium

Year:  2019        PMID: 35821894      PMCID: PMC9273010          DOI: 10.1055/s-0037-1610861

Source DB:  PubMed          Journal:  Synlett        ISSN: 0936-5214            Impact factor:   2.170


  26 in total

1.  Convenient acylative dealkylation of tertiary amines

Authors: 
Journal:  J Org Chem       Date:  2000-02-25       Impact factor: 4.354

2.  SAR and biological evaluation of 3-azabicyclo[3.1.0]hexane derivatives as μ opioid ligands.

Authors:  Graham Lunn; Lee R Roberts; Stephane Content; Douglas J Critcher; Sara Douglas; Ashley E Fenwick; David M Gethin; Graham Goodwin; David Greenway; Sean Greenwood; Kim Hall; Martin Thomas; Stephen Thompson; David Williams; Gavin Wood; Andrew Wylie
Journal:  Bioorg Med Chem Lett       Date:  2012-02-02       Impact factor: 2.823

3.  Tripyrrolidinophosphoric acid triamide as an activator in samarium diiodide reductions.

Authors:  Chriss E McDonald; Jeremy D Ramsey; David G Sampsell; Julie A Butler; Michael R Cecchini
Journal:  Org Lett       Date:  2010-10-27       Impact factor: 6.005

Review 4.  Molecular complexity and fragment-based drug discovery: ten years on.

Authors:  Andrew R Leach; Michael M Hann
Journal:  Curr Opin Chem Biol       Date:  2011-06-12       Impact factor: 8.822

Review 5.  Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals.

Authors:  Edon Vitaku; David T Smith; Jon T Njardarson
Journal:  J Med Chem       Date:  2014-10-07       Impact factor: 7.446

Review 6.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

7.  Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells.

Authors:  Stuart Jones; Jonathan Ahmet; Kelly Ayton; Matthew Ball; Mark Cockerill; Emma Fairweather; Nicola Hamilton; Paul Harper; James Hitchin; Allan Jordan; Colin Levy; Ruth Lopez; Eddie McKenzie; Martin Packer; Darren Plant; Iain Simpson; Peter Simpson; Ian Sinclair; Tim C P Somervaille; Helen Small; Gary J Spencer; Graeme Thomson; Michael Tonge; Ian Waddell; Jarrod Walsh; Bohdan Waszkowycz; Mark Wigglesworth; Daniel H Wiseman; Donald Ogilvie
Journal:  J Med Chem       Date:  2016-12-05       Impact factor: 7.446

Review 8.  Fragment-to-Lead Medicinal Chemistry Publications in 2016.

Authors:  Christopher N Johnson; Daniel A Erlanson; Wolfgang Jahnke; Paul N Mortenson; David C Rees
Journal:  J Med Chem       Date:  2017-10-31       Impact factor: 7.446

9.  Toxicity of hexamethylphosphoramide in rats.

Authors:  R Kimbrough; T B Gaines
Journal:  Nature       Date:  1966-07-09       Impact factor: 49.962

Review 10.  Evaluating New Chemistry to Drive Molecular Discovery: Fit for Purpose?

Authors:  Daniel J Foley; Adam Nelson; Stephen P Marsden
Journal:  Angew Chem Int Ed Engl       Date:  2016-08-30       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.